good news and bad news about Vioxx
May 2002
The good news and bad news about Vioxx is creating questions.
GI safety. Vioxx (rofecoxib) reduces the risk of GI bleeding and perforations by 50% compared to naproxen.
Vioxx is the first COX-2 inhibitor with proof acceptable to the FDA that it causes fewer serious ulcers than a traditional NSAID.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote